National Inst. of Allergy and Infectious Disease|
Website : http://www.niaid.nih.gov
NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world.
Expanded NIAID Research Portfolio
The scope of the NIAID research portfolio has expanded considerably in recent years in response to new challenges such as:
- Emerging and re-emerging infectious diseases including:
- acquired immunodeficiency syndrome (AIDS)
- severe acute respiratory syndrome (SARS)
- West Nile virus
- Increase in asthma prevalence among children in this country
The growth of NIAID programs also has been driven by unprecedented scientific opportunities in the core NIAID scientific disciplines of:
- Infectious diseases
Advances in these key fields have led to a better understanding of the human immune system and the mechanisms of infectious and immune-mediated diseases.
Current Open Positions